The global market for Sex Hormone Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The driving factors for sex hormone drugs mainly include the following aspects:

Disease treatment needs: Sex hormone drugs are mainly used to treat sexual dysfunction, infertility, menopausal syndrome and other diseases. These diseases have a great impact on patients" physical and mental health, so sex hormone drugs are needed to relieve symptoms and improve quality of life.

Aging of the population: As the aging of the population intensifies, the incidence of age-related diseases such as menopausal syndrome is gradually increasing, which has further promoted the development of the sex hormone drug market.

Increased awareness of self-care: As people pay more and more attention to health and self-care, more and more people are paying attention to their physical conditions and taking measures for prevention and treatment. As an effective health care method, sex hormone drugs have attracted more and more people"s attention and recognition.

Progress in drug research and development: With the continuous advancement of science and technology, the research and development of sex hormone drugs is also making continuous progress. The emergence of new varieties and new dosage forms provides patients with more choices and better treatment effects, and further promotes the development of the sex hormone drug market.

Improvement of the medical security system: With the continuous improvement of the global medical security system, people can obtain sex hormone drugs more conveniently, which also provides favorable conditions for the development of the sex hormone drug market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sex Hormone Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sex Hormone Drugs.

The Sex Hormone Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sex Hormone Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sex Hormone Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Sex Hormone Drugs Market Report

Report Metric	Details
Report Name	Sex Hormone Drugs Market
Segment by Type	Progestins Male Hormones Estrogens
Segment by Application	Hospital Clinic Pharmacy Online Mall
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Teva Pharmaceuticals, Bayer, Merck, Teva Generics, Besins Healthcare, Virtus Pharmaceuticals, LLC, BionPharma, Aquatic Remedies, Xianju Pharmaceutical, Zhejiang Aisheng Pharmaceutical, Zhejiang Medicine, Hubei Dongxin Pharmaceutical, Tianjin Kingyork Group, Guangzhou Baiyunshan Mingxing Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Sex Hormone Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Sex Hormone Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sex Hormone Drugs Market report?

Ans: The main players in the Sex Hormone Drugs Market are Pfizer, Teva Pharmaceuticals, Bayer, Merck, Teva Generics, Besins Healthcare, Virtus Pharmaceuticals, LLC, BionPharma, Aquatic Remedies, Xianju Pharmaceutical, Zhejiang Aisheng Pharmaceutical, Zhejiang Medicine, Hubei Dongxin Pharmaceutical, Tianjin Kingyork Group, Guangzhou Baiyunshan Mingxing Pharmaceutical

What are the Application segmentation covered in the Sex Hormone Drugs Market report?

Ans: The Applications covered in the Sex Hormone Drugs Market report are Hospital Clinic, Pharmacy, Online Mall

What are the Type segmentation covered in the Sex Hormone Drugs Market report?

Ans: The Types covered in the Sex Hormone Drugs Market report are Progestins, Male Hormones, Estrogens

1 Sex Hormone Drugs Market Overview

1.1 Product Definition

1.2 Sex Hormone Drugs by Type

1.2.1 Global Sex Hormone Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Progestins

1.2.3 Male Hormones

1.2.4 Estrogens

1.3 Sex Hormone Drugs by Application

1.3.1 Global Sex Hormone Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospital Clinic

1.3.3 Pharmacy

1.3.4 Online Mall

1.4 Global Sex Hormone Drugs Market Size Estimates and Forecasts

1.4.1 Global Sex Hormone Drugs Revenue 2020-2031

1.4.2 Global Sex Hormone Drugs Sales 2020-2031

1.4.3 Global Sex Hormone Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Sex Hormone Drugs Market Competition by Manufacturers

2.1 Global Sex Hormone Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Sex Hormone Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Sex Hormone Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Sex Hormone Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Sex Hormone Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Sex Hormone Drugs, Product Type & Application

2.7 Global Key Manufacturers of Sex Hormone Drugs, Date of Enter into This Industry

2.8 Global Sex Hormone Drugs Market Competitive Situation and Trends

2.8.1 Global Sex Hormone Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Sex Hormone Drugs Players Market Share by Revenue

2.8.3 Global Sex Hormone Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Sex Hormone Drugs Market Scenario by Region

3.1 Global Sex Hormone Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Sex Hormone Drugs Sales by Region: 2020-2031

3.2.1 Global Sex Hormone Drugs Sales by Region: 2020-2025

3.2.2 Global Sex Hormone Drugs Sales by Region: 2026-2031

3.3 Global Sex Hormone Drugs Revenue by Region: 2020-2031

3.3.1 Global Sex Hormone Drugs Revenue by Region: 2020-2025

3.3.2 Global Sex Hormone Drugs Revenue by Region: 2026-2031

3.4 North America Sex Hormone Drugs Market Facts & Figures by Country

3.4.1 North America Sex Hormone Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Sex Hormone Drugs Sales by Country (2020-2031)

3.4.3 North America Sex Hormone Drugs Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Sex Hormone Drugs Market Facts & Figures by Country

3.5.1 Europe Sex Hormone Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Sex Hormone Drugs Sales by Country (2020-2031)

3.5.3 Europe Sex Hormone Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Sex Hormone Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Sex Hormone Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Sex Hormone Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Sex Hormone Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Sex Hormone Drugs Market Facts & Figures by Country

3.7.1 Latin America Sex Hormone Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Sex Hormone Drugs Sales by Country (2020-2031)

3.7.3 Latin America Sex Hormone Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Sex Hormone Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Sex Hormone Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Sex Hormone Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Sex Hormone Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Sex Hormone Drugs Sales by Type (2020-2031)

4.1.1 Global Sex Hormone Drugs Sales by Type (2020-2025)

4.1.2 Global Sex Hormone Drugs Sales by Type (2026-2031)

4.1.3 Global Sex Hormone Drugs Sales Market Share by Type (2020-2031)

4.2 Global Sex Hormone Drugs Revenue by Type (2020-2031)

4.2.1 Global Sex Hormone Drugs Revenue by Type (2020-2025)

4.2.2 Global Sex Hormone Drugs Revenue by Type (2026-2031)

4.2.3 Global Sex Hormone Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Sex Hormone Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Sex Hormone Drugs Sales by Application (2020-2031)

5.1.1 Global Sex Hormone Drugs Sales by Application (2020-2025)

5.1.2 Global Sex Hormone Drugs Sales by Application (2026-2031)

5.1.3 Global Sex Hormone Drugs Sales Market Share by Application (2020-2031)

5.2 Global Sex Hormone Drugs Revenue by Application (2020-2031)

5.2.1 Global Sex Hormone Drugs Revenue by Application (2020-2025)

5.2.2 Global Sex Hormone Drugs Revenue by Application (2026-2031)

5.2.3 Global Sex Hormone Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Sex Hormone Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Sex Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pfizer Sex Hormone Drugs Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Teva Pharmaceuticals

6.2.1 Teva Pharmaceuticals Company Information

6.2.2 Teva Pharmaceuticals Description and Business Overview

6.2.3 Teva Pharmaceuticals Sex Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Teva Pharmaceuticals Sex Hormone Drugs Product Portfolio

6.2.5 Teva Pharmaceuticals Recent Developments/Updates

6.3 Bayer

6.3.1 Bayer Company Information

6.3.2 Bayer Description and Business Overview

6.3.3 Bayer Sex Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Bayer Sex Hormone Drugs Product Portfolio

6.3.5 Bayer Recent Developments/Updates

6.4 Merck

6.4.1 Merck Company Information

6.4.2 Merck Description and Business Overview

6.4.3 Merck Sex Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Merck Sex Hormone Drugs Product Portfolio

6.4.5 Merck Recent Developments/Updates

6.5 Teva Generics

6.5.1 Teva Generics Company Information

6.5.2 Teva Generics Description and Business Overview

6.5.3 Teva Generics Sex Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Teva Generics Sex Hormone Drugs Product Portfolio

6.5.5 Teva Generics Recent Developments/Updates

6.6 Besins Healthcare

6.6.1 Besins Healthcare Company Information

6.6.2 Besins Healthcare Description and Business Overview

6.6.3 Besins Healthcare Sex Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Besins Healthcare Sex Hormone Drugs Product Portfolio

6.6.5 Besins Healthcare Recent Developments/Updates

6.7 Virtus Pharmaceuticals, LLC

6.7.1 Virtus Pharmaceuticals, LLC Company Information

6.7.2 Virtus Pharmaceuticals, LLC Description and Business Overview

6.7.3 Virtus Pharmaceuticals, LLC Sex Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Virtus Pharmaceuticals, LLC Sex Hormone Drugs Product Portfolio

6.7.5 Virtus Pharmaceuticals, LLC Recent Developments/Updates

6.8 BionPharma

6.8.1 BionPharma Company Information

6.8.2 BionPharma Description and Business Overview

6.8.3 BionPharma Sex Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 BionPharma Sex Hormone Drugs Product Portfolio

6.8.5 BionPharma Recent Developments/Updates

6.9 Aquatic Remedies

6.9.1 Aquatic Remedies Company Information

6.9.2 Aquatic Remedies Description and Business Overview

6.9.3 Aquatic Remedies Sex Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Aquatic Remedies Sex Hormone Drugs Product Portfolio

6.9.5 Aquatic Remedies Recent Developments/Updates

6.10 Xianju Pharmaceutical

6.10.1 Xianju Pharmaceutical Company Information

6.10.2 Xianju Pharmaceutical Description and Business Overview

6.10.3 Xianju Pharmaceutical Sex Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Xianju Pharmaceutical Sex Hormone Drugs Product Portfolio

6.10.5 Xianju Pharmaceutical Recent Developments/Updates

6.11 Zhejiang Aisheng Pharmaceutical

6.11.1 Zhejiang Aisheng Pharmaceutical Company Information

6.11.2 Zhejiang Aisheng Pharmaceutical Description and Business Overview

6.11.3 Zhejiang Aisheng Pharmaceutical Sex Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Zhejiang Aisheng Pharmaceutical Sex Hormone Drugs Product Portfolio

6.11.5 Zhejiang Aisheng Pharmaceutical Recent Developments/Updates

6.12 Zhejiang Medicine

6.12.1 Zhejiang Medicine Company Information

6.12.2 Zhejiang Medicine Description and Business Overview

6.12.3 Zhejiang Medicine Sex Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Zhejiang Medicine Sex Hormone Drugs Product Portfolio

6.12.5 Zhejiang Medicine Recent Developments/Updates

6.13 Hubei Dongxin Pharmaceutical

6.13.1 Hubei Dongxin Pharmaceutical Company Information

6.13.2 Hubei Dongxin Pharmaceutical Description and Business Overview

6.13.3 Hubei Dongxin Pharmaceutical Sex Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Hubei Dongxin Pharmaceutical Sex Hormone Drugs Product Portfolio

6.13.5 Hubei Dongxin Pharmaceutical Recent Developments/Updates

6.14 Tianjin Kingyork Group

6.14.1 Tianjin Kingyork Group Company Information

6.14.2 Tianjin Kingyork Group Description and Business Overview

6.14.3 Tianjin Kingyork Group Sex Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Tianjin Kingyork Group Sex Hormone Drugs Product Portfolio

6.14.5 Tianjin Kingyork Group Recent Developments/Updates

6.15 Guangzhou Baiyunshan Mingxing Pharmaceutical

6.15.1 Guangzhou Baiyunshan Mingxing Pharmaceutical Company Information

6.15.2 Guangzhou Baiyunshan Mingxing Pharmaceutical Description and Business Overview

6.15.3 Guangzhou Baiyunshan Mingxing Pharmaceutical Sex Hormone Drugs Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Guangzhou Baiyunshan Mingxing Pharmaceutical Sex Hormone Drugs Product Portfolio

6.15.5 Guangzhou Baiyunshan Mingxing Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Sex Hormone Drugs Industry Chain Analysis

7.2 Sex Hormone Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Sex Hormone Drugs Production Mode & Process Analysis

7.4 Sex Hormone Drugs Sales and Marketing

7.4.1 Sex Hormone Drugs Sales Channels

7.4.2 Sex Hormone Drugs Distributors

7.5 Sex Hormone Drugs Customer Analysis

8 Sex Hormone Drugs Market Dynamics

8.1 Sex Hormone Drugs Industry Trends

8.2 Sex Hormone Drugs Market Drivers

8.3 Sex Hormone Drugs Market Challenges

8.4 Sex Hormone Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

VIRTUS PHARMACEUTICALS LLC

Bionpharma

Aquatic Remedies

Xianju Pharmaceutical

Zhejiang Aisheng Pharmaceutical

Zhejiang Medicine

Hubei Dongxin Pharmaceutical

TianJin KingYork Group

Guangzhou Baiyunshan Mingxing Pharmaceutical

List of Tables

Table 1. Global Sex Hormone Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Sex Hormone Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Sex Hormone Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Sex Hormone Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Sex Hormone Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Sex Hormone Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Sex Hormone Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Sex Hormone Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Sex Hormone Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Sex Hormone Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Sex Hormone Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Sex Hormone Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Sex Hormone Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sex Hormone Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Sex Hormone Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Sex Hormone Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Sex Hormone Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Sex Hormone Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Sex Hormone Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Sex Hormone Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Sex Hormone Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Sex Hormone Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Sex Hormone Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Sex Hormone Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Sex Hormone Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Sex Hormone Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Sex Hormone Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Sex Hormone Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Sex Hormone Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Sex Hormone Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Sex Hormone Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Sex Hormone Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Sex Hormone Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Sex Hormone Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Sex Hormone Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Sex Hormone Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Sex Hormone Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Sex Hormone Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Sex Hormone Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Sex Hormone Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Sex Hormone Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Sex Hormone Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Sex Hormone Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Sex Hormone Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Sex Hormone Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Sex Hormone Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Sex Hormone Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Sex Hormone Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Sex Hormone Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Sex Hormone Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Sex Hormone Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Sex Hormone Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Sex Hormone Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Sex Hormone Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Sex Hormone Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Sex Hormone Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Sex Hormone Drugs Price (US$/Unit) by Type (2020-2025)

Table 59. Global Sex Hormone Drugs Price (US$/Unit) by Type (2026-2031)

Table 60. Global Sex Hormone Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Sex Hormone Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Sex Hormone Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Sex Hormone Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Sex Hormone Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Sex Hormone Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Sex Hormone Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Sex Hormone Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Sex Hormone Drugs Price (US$/Unit) by Application (2020-2025)

Table 69. Global Sex Hormone Drugs Price (US$/Unit) by Application (2026-2031)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Sex Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Pfizer Sex Hormone Drugs Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Teva Pharmaceuticals Company Information

Table 76. Teva Pharmaceuticals Description and Business Overview

Table 77. Teva Pharmaceuticals Sex Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Teva Pharmaceuticals Sex Hormone Drugs Product

Table 79. Teva Pharmaceuticals Recent Developments/Updates

Table 80. Bayer Company Information

Table 81. Bayer Description and Business Overview

Table 82. Bayer Sex Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Bayer Sex Hormone Drugs Product

Table 84. Bayer Recent Developments/Updates

Table 85. Merck Company Information

Table 86. Merck Description and Business Overview

Table 87. Merck Sex Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Merck Sex Hormone Drugs Product

Table 89. Merck Recent Developments/Updates

Table 90. Teva Generics Company Information

Table 91. Teva Generics Description and Business Overview

Table 92. Teva Generics Sex Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Teva Generics Sex Hormone Drugs Product

Table 94. Teva Generics Recent Developments/Updates

Table 95. Besins Healthcare Company Information

Table 96. Besins Healthcare Description and Business Overview

Table 97. Besins Healthcare Sex Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Besins Healthcare Sex Hormone Drugs Product

Table 99. Besins Healthcare Recent Developments/Updates

Table 100. Virtus Pharmaceuticals, LLC Company Information

Table 101. Virtus Pharmaceuticals, LLC Description and Business Overview

Table 102. Virtus Pharmaceuticals, LLC Sex Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Virtus Pharmaceuticals, LLC Sex Hormone Drugs Product

Table 104. Virtus Pharmaceuticals, LLC Recent Developments/Updates

Table 105. BionPharma Company Information

Table 106. BionPharma Description and Business Overview

Table 107. BionPharma Sex Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. BionPharma Sex Hormone Drugs Product

Table 109. BionPharma Recent Developments/Updates

Table 110. Aquatic Remedies Company Information

Table 111. Aquatic Remedies Description and Business Overview

Table 112. Aquatic Remedies Sex Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Aquatic Remedies Sex Hormone Drugs Product

Table 114. Aquatic Remedies Recent Developments/Updates

Table 115. Xianju Pharmaceutical Company Information

Table 116. Xianju Pharmaceutical Description and Business Overview

Table 117. Xianju Pharmaceutical Sex Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Xianju Pharmaceutical Sex Hormone Drugs Product

Table 119. Xianju Pharmaceutical Recent Developments/Updates

Table 120. Zhejiang Aisheng Pharmaceutical Company Information

Table 121. Zhejiang Aisheng Pharmaceutical Description and Business Overview

Table 122. Zhejiang Aisheng Pharmaceutical Sex Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Zhejiang Aisheng Pharmaceutical Sex Hormone Drugs Product

Table 124. Zhejiang Aisheng Pharmaceutical Recent Developments/Updates

Table 125. Zhejiang Medicine Company Information

Table 126. Zhejiang Medicine Description and Business Overview

Table 127. Zhejiang Medicine Sex Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Zhejiang Medicine Sex Hormone Drugs Product

Table 129. Zhejiang Medicine Recent Developments/Updates

Table 130. Hubei Dongxin Pharmaceutical Company Information

Table 131. Hubei Dongxin Pharmaceutical Description and Business Overview

Table 132. Hubei Dongxin Pharmaceutical Sex Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Hubei Dongxin Pharmaceutical Sex Hormone Drugs Product

Table 134. Hubei Dongxin Pharmaceutical Recent Developments/Updates

Table 135. Tianjin Kingyork Group Company Information

Table 136. Tianjin Kingyork Group Description and Business Overview

Table 137. Tianjin Kingyork Group Sex Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Tianjin Kingyork Group Sex Hormone Drugs Product

Table 139. Tianjin Kingyork Group Recent Developments/Updates

Table 140. Guangzhou Baiyunshan Mingxing Pharmaceutical Company Information

Table 141. Guangzhou Baiyunshan Mingxing Pharmaceutical Description and Business Overview

Table 142. Guangzhou Baiyunshan Mingxing Pharmaceutical Sex Hormone Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. Guangzhou Baiyunshan Mingxing Pharmaceutical Sex Hormone Drugs Product

Table 144. Guangzhou Baiyunshan Mingxing Pharmaceutical Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Sex Hormone Drugs Distributors List

Table 148. Sex Hormone Drugs Customers List

Table 149. Sex Hormone Drugs Market Trends

Table 150. Sex Hormone Drugs Market Drivers

Table 151. Sex Hormone Drugs Market Challenges

Table 152. Sex Hormone Drugs Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. Product Picture of Sex Hormone Drugs

Figure 2. Global Sex Hormone Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Sex Hormone Drugs Market Share by Type: 2024 & 2031

Figure 4. Progestins Product Picture

Figure 5. Male Hormones Product Picture

Figure 6. Estrogens Product Picture

Figure 7. Global Sex Hormone Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Sex Hormone Drugs Market Share by Application: 2024 & 2031

Figure 9. Hospital Clinic

Figure 10. Pharmacy

Figure 11. Online Mall

Figure 12. Global Sex Hormone Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Sex Hormone Drugs Market Size (2020-2031) & (US$ Million)

Figure 14. Global Sex Hormone Drugs Sales (2020-2031) & (K Units)

Figure 15. Global Sex Hormone Drugs Average Price (US$/Unit) & (2020-2031)

Figure 16. Sex Hormone Drugs Report Years Considered

Figure 17. Sex Hormone Drugs Sales Share by Manufacturers in 2024

Figure 18. Global Sex Hormone Drugs Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Sex Hormone Drugs Players: Market Share by Revenue in Sex Hormone Drugs in 2024

Figure 20. Sex Hormone Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Sex Hormone Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Sex Hormone Drugs Sales Market Share by Country (2020-2031)

Figure 23. North America Sex Hormone Drugs Revenue Market Share by Country (2020-2031)

Figure 24. United States Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Sex Hormone Drugs Sales Market Share by Country (2020-2031)

Figure 27. Europe Sex Hormone Drugs Revenue Market Share by Country (2020-2031)

Figure 28. Germany Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Sex Hormone Drugs Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Sex Hormone Drugs Revenue Market Share by Region (2020-2031)

Figure 35. China Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Sex Hormone Drugs Sales Market Share by Country (2020-2031)

Figure 43. Latin America Sex Hormone Drugs Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Sex Hormone Drugs Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Sex Hormone Drugs Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Sex Hormone Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Sex Hormone Drugs by Type (2020-2031)

Figure 53. Global Revenue Market Share of Sex Hormone Drugs by Type (2020-2031)

Figure 54. Global Sex Hormone Drugs Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Sex Hormone Drugs by Application (2020-2031)

Figure 56. Global Revenue Market Share of Sex Hormone Drugs by Application (2020-2031)

Figure 57. Global Sex Hormone Drugs Price (US$/Unit) by Application (2020-2031)

Figure 58. Sex Hormone Drugs Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions